Dr. Zandberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Avenue
Pittsburgh, PA 15232Phone+1 412-641-1000Fax+1 412-641-1221
Education & Training
- University of MarylandFellowship, Hematology and Medical Oncology, 2009 - 2012
- George Washington UniversityResidency, Internal Medicine, 2005 - 2008
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
- PA State Medical License 2018 - 2024
- MD State Medical License 2012 - 2019
- VA State Medical License 2005 - 2010
- DC State Medical License 2005 - 2008
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
- Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Oct 23
- Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Start of enrollment: 2019 Jan 10
- Join now to see all
Publications & Presentations
PubMed
- 420 citationsThe Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison
Journal for Immunotherapy of Cancer. 2019-07-15 - 73 citationsImproving head and neck cancer therapies by immunomodulation of the tumour microenvironment.Ayana T Ruffin, Housaiyin Li, Lazar Vujanovic, Dan P Zandberg, Robert L Ferris
Nature Reviews. Cancer. 2023-03-01 - 28 citationsEmergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007.Dan P. Zandberg, Sandy Liu, Olga Goloubeva, Lisa M. Schumaker, Kevin J. Cullen
Cancer Prevention Research. 2015-01-01
Journal Articles
- Intratumor Genetic Heterogeneity in Squamous Cell Carcinoma of the Oral CavityScott E Strome, John C Papadimitriou, Dan P Zandberg, Head & Neck
Press Mentions
- OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical StudyJanuary 28th, 2021
- Hill Day Advocates Present Unified Voice in Support of NIH, NCI FundingMay 1st, 2019
- Taking Treatment & a Half Marathon, Together, One Step at A TimeOctober 2nd, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: